• 1
    Rao KN 1995 The significance of the cholesterol biosynthetic pathway in cell growth and carcinogenesis. Anticancer Research 15: 309314.
  • 2
    Porter JA, Young KE, Beachy PA 1996 Cholesterol modification of hedgehog signaling proteins in animal development. Science 274: 255259.
  • 3
    Edwards PA, Ericsson J 1999 Sterols and isoprenoids: Signaling molecules derived from the cholesterol biosynthetic pathway. Annu Rev Biochem 68: 157185.
  • 4
    Russell DW 1992 Cholesterol biosynthesis and metabolism. Cardiovasc Drugs Ther 6: 103110.
  • 5
    Ross R 1999 Atherosclerosis—An inflammatory disease. N Engl J Med 340: 115126.
  • 6
    Parhami F, Garfinkel A, Demer LL 2000 Role of lipids in osteoporosis. Arterioscler Thromb Vasc Biol 20: 23462348.
  • 7
    Mullender MG, van der Meer DD, Huiskes R, Lips P 1996 Osteocyte density changes in aging and osteoporosis. Bone 18: 109113.
  • 8
    Kruger MC, Horrobin DF 1997 Calcium metabolism, osteoporosis and essential fatty acids: A review. Prog Lipid Res 36: 131151.
  • 9
    Watkins BA, Shen CL, McMurtry JP, Xu H, Bain SD, Allen KGD, Seifert MF 1997 Dietary lipids modulate bone prostaglandin E2 production, insulin-like growth factor-I concentration and formation rate in chicks. J Nutr 127: 10841091.
  • 10
    Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, Boyce B, Zhao M, Gutierrez G 1999 Stimulation of bone formation in vitro and in rodents by statins. Science 286: 19461949.
  • 11
    Maeda T, Matsunuma A, Kawane T, Horiuchi N 2001 Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells. Biochem Biophys Res Commun 280: 874877.
  • 12
    Nuckolls GH, Kane A, Shum L, Slavkin HC 2000 Lovastatin promotes cartilage growth but inhibits endochondral ossification of the cranial base in organ culture. J Bone Miner Res 15: S1;S426. (abstract)
  • 13
    Meier CR, Schlienger RG, Kraenzlin ME, Schlegel B, Jick H 2000 HMG-CoA reductase inhibitors and the risk of fractures. JAMA 283: 32053210.
  • 14
    Chan KA, Andrade SE, Boles M, Buist DSM, Chase GA, Donahue JG, Goodman MJ, Gurwitz JH, LaCriox AZ, Platt R 2000 Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women. Lancet 355: 21852188.
  • 15
    Reid IR, Hague W, Emberson J, Baker J, Tonkin A, Hunt D, MacMahon S, Sharpe N 2001 Effect of pravastatin on frequency of fracture in the LIPID study: Secondary analysis of a randomized controlled trial. Long-term intervention with paravastatin in ischaemic disease. Lancet 357: 509512.
  • 16
    Goldstein JL, Brown MS 1990 Regulation of mevalonate pathway. Nature 343: 425430.
  • 17
    Alberts AW, Chen J, Kuron G, Hunt V, Huff J, Hoffman C, Rothrock J, Lopez M, Joshua H, Harris E, Patchett A, Monaghan R, Currie S, Stapley E, Albers-Schonberg G, Hensens O, Hirshfield J, Hoogsteen K, Liesch J, Springer J 1980 Mevinolin: A highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent. Proc Natl Acad Sci USA 77: 39573961.
  • 18
    Stein G, Lian J 1993 Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev 14: 424442.
  • 19
    Kobayashi T, Sugimoto T, Kanzawa M, Chihara K 1998 Identification of an enhancer sequence in 5′-flanking region of 1A exon of mouse liver/bone/kidney-type alkaline phosphatase gene. Biochem Mol Biol Intern 44: 683691.
  • 20
    Parhami F, Jackson SM, Tintut Y, Le V, Balucan JP, Territo M, Demer LL 1999 Atherogenic diet and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic differentiation of marrow stromal cells. J Bone Miner Res 14: 20672078.
  • 21
    Mody N, Parhami F, Sarafian TA, Demer LL 2001 Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Rad Biol Med 31: 509519.
  • 22
    Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD, Tintut Y, Berliner JA, Demer LL 1997 Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation: A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol 17: 680687.
  • 23
    Tintut Y, Patel J, Parhami F, Demer LL 2000 Tumor necrosis factor-α promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 102: 26362642.
  • 24
    Martin G, Duez H, Blanquart C, Berezowski V, Poulain P, Fruchart JC, Najib-Fruchart J, Glineur C, Staels B 2001 Statin-induced inhibition of the Rho-signaling pathway activates PPARα and induces HDL apo-AI. J Clin Invest 107: 14231432.
  • 25
    Gianni M, Terao M, Paolo N, Barbui T, Rambaldi A, Garattini E 1995 All-trans retinoic acid and cyclic adenosine monophosphate cooperate in the expression of leukocyte alkaline phosphatase in acute promyelocytic leukemia cells. Blood 85: 36193635.
  • 26
    Heath JK, Suva LJ, Yoon K, Kiledjian M, Martin TJ, Rodan GA 1992 Retinoic acid stimulates transcriptional activity from the alkaline phosphatase promoter in the immortalized rat calvarial cell line, RTC-1. Mol Endocrinol 6: 636646.
  • 27
    Kiledjian M, Kadesch T 1991 Post-transcriptional regulation of the human liver/bone/kidney alkaline phosphatase gene. J Biol Chem 266: 42074213.
  • 28
    Hui M, Tenenbaum HC 1998 New face of an old enzyme: Alkaline phosphatase may contribute to human tissue aging by inducing tissue hardening and calcification. Anat Rec 253: 9194.
  • 29
    Bellows CG, Aubin JE, Heersche JNM 1991 Initiation and progression of mineralization of bone nodules formed in vitro: The role of alkaline phosphatase and organic phosphate. Bone Miner 14: 2740.
  • 30
    Klein BY, Gal I, Segal D 1993 Studies of the levamisole inhibitory effect on rat stromal-cell commitment to mineralization. J Cell Biochem 53: 114121.
  • 31
    Prockop DJ 1997 Marrow stromal cells as stem cells for non-hematopoietic tissues. Science 276: 7174.
  • 32
    Bergman RJ, Gazit D, Kahn AJ, Gruber H, McDougall S, Hahn TJ 1996 Age-related changes in osteogenic stem cells in mice. J Bone Miner Res 11: 568577.
  • 33
    Majors AK, Boehm CA, Nitto H, Midura RJ, Muschler GF 1997 Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation. J Orthop Res 15: 546557.
  • 34
    Krishnan V, Yanfei LMA, Moseley JM, Geiser AG, Friant S, Frolik CA 2001 Bone anabolic effects of Sonic/Indian hedgehog are mediated by BMP-2/4-dependent pathways in the neonatal rat metatarsal model. Endocrinology 142: 940947.
  • 35
    Murtaugh LC, Chyung JH, Lassar AB 1999 Sonic hedgehog promotes somitic chondrogenesis by altering the cellular response to BMP signaling. Genes Dev 13: 225237.
  • 36
    Chung Y, Lee M, Lee S, Kim H, Fitzpatrick LA 2000 HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients. J Clin Endocrinol Metab 85: 11371142.
  • 37
    Edwards CJ, Hart DJ, Spector TD 2000 Oral statins and increased bone mineral density in postmenopausal women. Lancet 355: 22182219.
  • 38
    Hamelin BA, Turgeon J 1998 Hydrophilicity/lipophilicity: Relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors. Trends Pharmacol Sci 19: 138.
  • 39
    Callister TQ, Raggi P, Cooil B, Lippolis NJ, Russo DJ 1998 Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med 339: 19721978.
  • 40
    Huang Y, Hall IH 1996 Synthesis and pharmacological studies of 3-amino-2-methyl-1-phenylpropanones as hypolipidemic agents in rodents. Arch Pharm (Weinheim) 329: 329338.
  • 41
    Parhami F, Tintut Y, Beamer WG, Gharavi N, Goodman W, Demer LL 2001 Atherogenic high-fat diet reduces bone mineralization in mice. J Bone Miner Res 16: 182188.
  • 42
    Fisher JE, Rogers MJ, Halasy JM, Luckman SP, Hughes DE, Masarachia PJ, Wesolowski G, Russell RGG, Rodan GA, Reszka AA 1999 Alendronate mechanism of action: Geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. Proc Natl Acad Sci USA 96: 133138.
  • 43
    Herold G, Jungwirth R, Rogler G, Geerling I, Stange EF 1995 Influence of cholesterol supply on cell growth and differentiation in cultured enterocytes (CaCo-2). Digestion 56: 5766.
  • 44
    Denning MF, Kazanietz MG, Blumberg PM, Yuspa SH 1995 Cholesterol sulfate activates multiple protein kinase C isoenzymes and induces granular cell differentiation in cultured murine keratinocytes. Cell Growth Differ 6: 16191626.